Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0FP8S
|
|||
| Former ID |
DIB013629
|
|||
| Drug Name |
Neugranin
|
|||
| Synonyms |
Albugranin; CG-10639; Granulocyte colony stimulating factor (long-acting), CoGenesys; Granulocyte colony stimulating factor (long-acting), Teva Pharmaceutical; Long-acting G-CSF, HGS; Long-acting G-CSF, Teva Pharmaceutical; G-SCF (long-acting), CoGenesys
Click to Show/Hide
|
|||
| Indication | Neutropenia [ICD-11: 4B00.0; ICD-9: 288] | Preregistration | [1] | |
| Company |
Aventis Behring LLC
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Granulocyte colony-stimulating factor (CSF3) | Target Info | Modulator | [2] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| PI3K-Akt signaling pathway | ||||
| Jak-STAT signaling pathway | ||||
| Hematopoietic cell lineage | ||||
| Malaria | ||||
| NetPath Pathway | IL1 Signaling Pathway | |||
| TNFalpha Signaling Pathway | ||||
| TCR Signaling Pathway | ||||
| WikiPathways | Cytokines and Inflammatory Response | |||
| Hematopoietic Stem Cell Differentiation | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017176) | |||
| REF 2 | Development and Characterization of a Novel Fusion Protein of a Mutated Granulocyte Colony-Stimulating Factor and Human Serum Albumin in Pichia pastoris. PLoS One. 2014; 9(12): e115840. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.